Charles Rosier
2024
2023
2022
2021
2020
2019
2024
CEO and Co-Founder of Augustinus Bader
A long-time biotech investor and supporter of medical research, Charles recognized the potential of Professor Bader’s breakthrough Wound Gel and partnered with him to form the Bader Group, a biotech company.
In 2018 they launched Augustinus Bader skincare with The Cream and The Rich Cream, translating Professor Bader’s medical technology into a cosmetic technology - TFC8®. The company has since expanded to include hair care and supplements and aims to help finance and further Professor Bader’s medical and clinical work on burns and diabetic wounds.
Prior to Augustinus Bader, Charles supported the work of French Professor Etienne Emile Baulieu on spinal cord injuries.
